Reactivation of hepatitis b in a long-term anti-hbs-positive patient after immunosuppressive therapy

##plugins.themes.academic_pro.article.sidebar##

Published Dec 2, 2015
Download
pdf
Vol. 93 No. 7 (2015): Issue Jul 2015

##plugins.themes.academic_pro.article.main##

Sondès Bizid
Mériam Sabbah
Hatem Ben Abdallah
Yosra Zaaimi
Riadh Bouali
Tarek Ben Othman
Nabil Abdelli

##plugins.themes.academic_pro.article.details##

References

  1. Romand F, Michallet M, Pichoud C, Trepo C et al. Réactivation virale B après greffe de moelle allogénique chez un malade précédemment guéri d'une hépatite virale B. Gastroenterol Clin Biol 1999 ;23:770-4 .
  2. Papatheodoridis G, Buti M, Cornberg M, Janssen H et al. EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection. Journal of Hepatology 2012 ;57:167-85
  3. Sugauchi F, Tanaka Y, Kusumoto S, Matsuura K, Sugiyama M, Kurbanov F, et al. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy. Med Virol 2011;83:412-8.
  4. Idilman R, Arat M, Soydan E, et al. Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies. J Viral Hepat 2004;11: 141-7
  5. Loomba R, Rowley A, Wesley R, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med 2008;148:519-28.